Play
Video

Current Studies

Clinical trials advance medical treatment and therapy to increase survival and quality of life.  

Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.  

Successful treatments we know today are the result of past clinical trials. 

Purpose

The purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the incidence of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation therapy given with the chemotherapy agent, cisplatin. Patients will receive RRx-001 or placebo before start of standard of care treatment.

For more information please visit https://clinicaltrials.gov/study/NCT05966194

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .